{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:36Z","timestamp":1791289776800,"version":"4.3.0"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"crossref","award":["2009002515-16 & 201200029519"],"award-info":[{"award-number":["2009002515-16 & 201200029519"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>\n                      Xanthomatosis associated with monoclonal gammopathy includes hyperlipidaemic xanthoma (\n                      <jats:styled-content style=\"fixed-case\">HX<\/jats:styled-content>\n                      ), normolipidaemic xanthoma (\n                      <jats:styled-content style=\"fixed-case\">NX<\/jats:styled-content>\n                      ) and necrobiotic xanthogranuloma (\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      ). All three pathologies are characterized by skin or visceral lesions related to cholesterol accumulation, monoclonal immunoglobulin (MIg) and hypocomplementemia. The pathophysiology underlying\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      remains unknown although the involvement of MIg is suspected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To provide further insights into the pathophysiology of\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      , we evaluated the plasma lipid phenotype, mechanisms involved in cellular cholesterol accumulation and role of MIg in an analysis of blood and plasma markers of inflammation in 16 patients with xanthomatosis [\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a08) and NX (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a08)] associated with monoclonal IgG relative to the relevant controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The lipid profile of patients with\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      was characterized by a low\n                      <jats:styled-content style=\"fixed-case\">HDL<\/jats:styled-content>\n                      \u2010C phenotype and an abnormal distribution of\n                      <jats:styled-content style=\"fixed-case\">HDL<\/jats:styled-content>\n                      particles. Sera from patients with\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      induced cholesterol accumulation in human macrophages. This accumulation was due in part to a significant reduction in the\n                      <jats:styled-content style=\"fixed-case\">HDL<\/jats:styled-content>\n                      capacity to promote cholesterol efflux from macrophages, which was not found in the case of\n                      <jats:styled-content style=\"fixed-case\">NX<\/jats:styled-content>\n                      . The MIg of NXG and NX patients was tested positively by ELISA to recognize a large spectrum of lipoproteins. High plasma levels of pro\u2010inflammatory cytokines (\n                      <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\n                      \u03b1 and IL\u20106), soluble cytokine receptors (sIL\u20106R, s\n                      <jats:styled-content style=\"fixed-case\">TNFRI<\/jats:styled-content>\n                      and s\n                      <jats:styled-content style=\"fixed-case\">TNFRII<\/jats:styled-content>\n                      ), adhesion molecules (\n                      <jats:styled-content style=\"fixed-case\">VCAM<\/jats:styled-content>\n                      \u20101 and\n                      <jats:styled-content style=\"fixed-case\">ICAM<\/jats:styled-content>\n                      \u20101) and chemokines (\n                      <jats:styled-content style=\"fixed-case\">MCP<\/jats:styled-content>\n                      \u20101, IL\u20108 and\n                      <jats:styled-content style=\"fixed-case\">MIP<\/jats:styled-content>\n                      \u20101\u03b1) were observed in both patients with\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">NX<\/jats:styled-content>\n                      , revealing a specific xanthoma inflammatory signature which was inversely correlated with plasma levels of anti\u2010inflammatory\n                      <jats:styled-content style=\"fixed-case\">HDL<\/jats:styled-content>\n                      . However, patients with\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      were distinguished by elevated levels of IL\u201015 and a marked increase in the rate of intermediate CD14++CD16+ monocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study revealed that\n                      <jats:styled-content style=\"fixed-case\">NXG<\/jats:styled-content>\n                      is characterized by impaired macrophage lipid homeostasis associated with a systemic inflammatory profile that may result from the interaction of MIg and lipoproteins.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/joim.12195","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T01:18:47Z","timestamp":1389835127000},"page":"269-284","source":"Crossref","is-referenced-by-count":43,"title":["Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy"],"prefix":"10.1111","volume":"276","author":[{"given":"R.","family":"Szalat","sequence":"first","affiliation":[{"name":"D\u00e9partement d'immunologie Clinique H\u00f4pital Saint Louis Paris France"},{"name":"EA3963 Universit\u00e9 Paris 7 Denis Diderot INSERM IFR105 Institut Universitaire d'H\u00e9matologie Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pirault","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010P.","family":"Fermand","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'immunologie Clinique H\u00f4pital Saint Louis Paris France"},{"name":"EA3963 Universit\u00e9 Paris 7 Denis Diderot INSERM IFR105 Institut Universitaire d'H\u00e9matologie Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carri\u00e9","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"},{"name":"Assistance\u2010Publique H\u00f4pitaux de Paris H\u00f4pital Piti\u00e9\u2010Salp\u00eatri\u00e8re Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saint\u2010Charles","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Olivier","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Robillard","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Frisdal","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. F.","family":"Villard","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cath\u00e9bras","sequence":"additional","affiliation":[{"name":"Service de m\u00e9decine interne h\u00f4pital Nord Saint\u2010Etienne Cedex 2 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bruckert","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"},{"name":"Assistance\u2010Publique H\u00f4pitaux de Paris H\u00f4pital Piti\u00e9\u2010Salp\u00eatri\u00e8re Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. John","family":"Chapman","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giral","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"},{"name":"Assistance\u2010Publique H\u00f4pitaux de Paris H\u00f4pital Piti\u00e9\u2010Salp\u00eatri\u00e8re Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guerin","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lesnik","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Le","family":"Goff","sequence":"additional","affiliation":[{"name":"INSERM UMR_S939 Dyslipidemia, Inflammation and Atherosclerosis in Metabolic Diseases Paris France"},{"name":"UPMC Univ Paris 06 UMR_S939 Paris France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054494"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-001164"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1986.01660230045008"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-356907"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03912.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113960"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0849-9"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2006.00013.x"},{"key":"e_1_2_9_10_1","first-page":"455","article-title":"Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa","volume":"39","author":"Baudet MF","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.1.64"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)00260-3"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.551"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.227181"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.1.189"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500255-JLR200"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.264325"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.194548"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328353ef07"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001689"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1586\/erc.11.16"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2010.11.005"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000146094.59640.13"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.211342"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301468"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.05.005"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.09.003"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2011.09.004"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.019"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq371"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.09.011"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0209082"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6581"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-326827"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326355"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoim.12195","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12195","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/joim.12195","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:44:16Z","timestamp":1695545056000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1111\/joim.12195"],"URL":"https:\/\/doi.org\/10.1111\/joim.12195","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,10]]}}}